Evidence method
Level · gp.fundamentals.debt_to_revenue
81.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
AKBA · Sep 30, 2025
Akebia Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001517022-25-000046General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.13% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
47.83% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
57.01% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
31.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
84.03% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
7.57% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.43% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.48% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 75.33%
- Current
- 81.07%
- Delta
- 5.74%
- Previous
- 0.20%
- Current
- 0.13%
- Delta
- -0.07%
- Previous
- 35.77%
- Current
- 47.83%
- Delta
- 12.06%
- Previous
- 43.13%
- Current
- 57.01%
- Delta
- 13.88%
- Previous
- 26.74%
- Current
- 31.72%
- Delta
- 4.98%
- Previous
- 84.12%
- Current
- 84.03%
- Delta
- -0.09%
- Previous
- 22.55%
- Current
- 7.57%
- Delta
- -14.98%
- Previous
- 17.63%
- Current
- 25.43%
- Delta
- 7.80%
- Previous
- 4.28%
- Current
- 5.48%
- Delta
- 1.20%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · AKBA Fundamental State →Transitioned To · AKBA CAPEX_INTENSITY_DECREASED →Transitioned To · AKBA CASH_GENERATION_INCREASED →Transitioned To · AKBA GROWTH_INCREASED →Transitioned To · AKBA INVENTORY_PRESSURE_INCREASED →Transitioned To · AKBA MARGIN_DECREASED →Transitioned To · AKBA PROFITABILITY_DECREASED →Transitioned To · AKBA R_AND_D_INTENSITY_INCREASED →Transitioned To · AKBA SBC_INTENSITY_INCREASED →Transitioned To · AKBA Fundamental State →Transitioned To · AKBA BALANCE_SHEET_LEVERAGE_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.